Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 131, Issue 24
June 14 2018
Issue Cover

Table of Contents

BLOOD COMMENTARIES

THROMBOSIS AND HEMOSTASIS
Btk inhibitors in atherosclerosis
Jonathan R. Lindner
View Articletitled, Btk inhibitors in atherosclerosis
Lymphoid Neoplasia
HBV messing with the B-cell genome leads to DLBCL
Marcella Visentini,Milvia Casato
View Articletitled, HBV messing with the B-cell genome leads to DLBCL
TRANSPLANTATION
Surviving childhood cancer: a sobering story
Mary Eapen
View Articletitled, Surviving childhood cancer: a sobering story

PLENARY PAPER

THROMBOSIS AND HEMOSTASIS
Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque–triggered thrombus formation in humans
Kristina Busygina,Janina Jamasbi,Till Seiler,Hans Deckmyn,Christian Weber,Richard Brandl,Reinhard Lorenz,Wolfgang Siess
View Articletitled, Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque–triggered thrombus formation in humans
Supplemental data

PERSPECTIVE

Introduction to a review series on emerging immunotherapies for hematologic diseases
Clinical Trials & Observations
Sophie Paczesny,Steven Z. Pavletic,Catherine M. Bollard
View Articletitled, Introduction to a review series on emerging immunotherapies for hematologic diseases

REVIEW SERIES

Chimeric antigen receptor–modified T cells: CD19 and the road beyond
Clinical Trials & Observations
Alexander I. Salter,Margot J. Pont,Stanley R. Riddell
View Articletitled, Chimeric antigen receptor–modified T cells: CD19 and the road beyond
Defining success with cellular therapeutics: the current landscape for clinical end point and toxicity analysis
Clinical Trials & Observations
Leslie S. Kean
View Articletitled, Defining success with cellular therapeutics: the current landscape for clinical end point and toxicity analysis
Vaccine therapy in hematologic malignancies
Clinical Trials & Observations
David Avigan,Jacalyn Rosenblatt
View Articletitled, Vaccine therapy in hematologic malignancies
Immune regulatory cell infusion for graft-versus-host disease prevention and therapy
Clinical Trials & Observations
Bruce R. Blazar,Kelli P. A. MacDonald,Geoffrey R. Hill
View Articletitled, Immune regulatory cell infusion for graft-versus-host disease prevention and therapy

CLINICAL TRIALS AND OBSERVATIONS

The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia
Clinical Trials & Observations
Eytan M. Stein,Guillermo Garcia-Manero,David A. Rizzieri,Raoul Tibes,Jesus G. Berdeja,Michael R. Savona,Mojca Jongen-Lavrenic,Jessica K. Altman,Blythe Thomson,Stephen J. Blakemore,Scott R. Daigle,Nigel J. Waters,A. Benjamin Suttle,Alicia Clawson,Roy Pollock,Andrei Krivtsov,Scott A. Armstrong,Jorge DiMartino,Eric Hedrick,Bob Löwenberg,Martin S. Tallman
View Articletitled, The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia
Supplemental data

LYMPHOID NEOPLASIA

Genetic landscape of hepatitis B virus–associated diffuse large B-cell lymphoma
Weicheng Ren,Xiaofei Ye,Hong Su,Wei Li,Dongbing Liu,Mohammad Pirmoradian,Xianhuo Wang,Bo Zhang,Qiang Zhang,Longyun Chen,Man Nie,Yao Liu,Bin Meng,Huiqiang Huang,Wenqi Jiang,Yixin Zeng,Wenyu Li,Kui Wu,Yong Hou,Klas G. Wiman,Zhiming Li,Huilai Zhang,Roujun Peng,Shida Zhu,Qiang Pan-Hammarström

Publisher's Note: There is a Blood Commentary on this article in this issue.

View Articletitled, Genetic landscape of hepatitis B virus–associated diffuse large B-cell lymphoma
Supplemental data

MYELOID NEOPLASIA

Gene dosage effect of CUX1 in a murine model disrupts HSC homeostasis and controls the severity and mortality of MDS
Ningfei An,Saira Khan,Molly K. Imgruet,Sandeep K. Gurbuxani,Stephanie N. Konecki,Michael R. Burgess,Megan E. McNerney
View Articletitled, Gene dosage effect of CUX1 in a murine model disrupts HSC homeostasis and controls the severity and mortality of MDS
Supplemental data
Ubiquitin-dependent degradation of CDK2 drives the therapeutic differentiation of AML by targeting PRDX2
Meidan Ying,Xuejing Shao,Hui Jing,Yujia Liu,Xiaotian Qi,Ji Cao,Yingqian Chen,Senfeng Xiang,Hua Song,Ronggui Hu,Guoqing Wei,Bo Yang,Qiaojun He
View Articletitled, Ubiquitin-dependent degradation of CDK2 drives the therapeutic differentiation of AML by targeting PRDX2
Supplemental data

THROMBOSIS AND HEMOSTASIS

Can thrombophilia predict recurrent catheter-related deep vein thrombosis in children?
Clinical Trials & Observations
M. Laura Avila,Nour Amiri,Sanja Stanojevic,Trang T. Vu,Katherine Barron,Peter Krol,Natasha Yue,Suzan Williams,Leonardo R. Brandão
View Articletitled, Can thrombophilia predict recurrent catheter-related deep vein thrombosis in children?

TRANSPLANTATION

Late mortality after autologous blood or marrow transplantation in childhood: a Blood or Marrow Transplant Survivor Study-2 report
Anna Sällfors Holmqvist,Yanjun Chen,Jessica Wu,Kevin Battles,Ravi Bhatia,Liton Francisco,Lindsey Hageman,Michelle Kung,Emily Ness,Mariel Parman,Donna Salzman,Jeanette Falck Winther,Joseph Rosenthal,Stephen J. Forman,Daniel J. Weisdorf,Mukta Arora,Saro H. Armenian,Smita Bhatia
View Articletitled, Late mortality after autologous blood or marrow transplantation in childhood: a Blood or Marrow Transplant Survivor Study-2 report
Supplemental data

LETTERS TO BLOOD

Associations between cohabitation status, treatment, and outcome in AML patients: a national population-based study
Clinical Trials & Observations
Lene Sofie Granfeldt Østgård,Mette Nørgaard,Bruno C. Medeiros,Marianne Tang Severinsen,Lone Smidstrup Friis,Claus Werenberg Marcher,Claudia Schoellkopf,Jan Maxwell Nørgaard
View Articletitled, Associations between cohabitation status, treatment, and outcome in AML patients: a national population-based study
Supplemental data
Nonspecific inhibition of erythropoiesis by short hairpin RNAs
Elizabeth A. Traxler,Christopher S. Thom,Yu Yao,Vikram Paralkar,Mitchell J. Weiss
View Articletitled, Nonspecific inhibition of erythropoiesis by short hairpin RNAs

BLOOD WORK

Gray platelet syndrome mimicking atypical autoimmune lymphoproliferative syndrome: the key is in the blood smear
Orna Steinberg-Shemer,Hannah Tamary
View Articletitled, Gray platelet syndrome mimicking atypical autoimmune lymphoproliferative syndrome: the key is in the blood smear
All Issues

Advertisement intended for health care professionals

Licking the wound with procoagulant vesicles
Approaching Hypercalcemia in Monoclonal Gammopathy of Undetermined Significance: Insights from the iStopMM study
CAR T-cells in autoimmunity: game changer or stepping stone?
Long-Term Efficacy and Safety of Danicopan as Add-On Therapy to Ravulizumab or Eculizumab in PNH With Significant EVH
How I treat quantitative fibrinogen disorders

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals